NORTH VANCOUVER, BC, July 23 /PRNewswire-FirstCall/ - Chromos Molecular Systems Inc. ("Chromos" or the "Company") announced today that the securities commissions or similar regulatory authorities in the Provinces of British Columbia, Alberta, Manitoba, Ontario and Quebec have revoked the cease trade orders against the Company effective July 22, 2008. As a result, there are currently no cease trade orders outstanding against the Company.
The Company continues to review its remaining business assets (which include the REM technology, certain rights to use the ACE System for gene therapy and transgenics, and its approximately 29% shareholding in Agrisoma Biosciences Inc.) to develop a strategic plan for continued operations for the longer term.
Certain statements in this news release may contain "forward-looking
statements" or "forward-looking information" within the meaning of
applicable securities legislation. Often, but not always, forward-looking
statements or information can be identified by the use of words such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or "does
not anticipate", or "believes" or variations of such words and phrases or
words and phrases that state or indicate that certain actions, events or
results "may", "could", "would", "might" or "will" be taken, occur or be
achieved. With respect to forward-looking statements and information
contained herein, we have made numerous assumptions. Although our
management believes that the assumptions made and the expectations
represented by such statements or information are reasonable, there can be
no assurance that a forward-looking statement or information herein will
prove to be accurate. Forward-looking statements and information by their
nature are based on assumptions and involve known and unknown risks,
uncertainties and other factors which may cause our actual
|SOURCE Chromos Molecular Systems Inc.|
Copyright©2008 PR Newswire.
All rights reserved